Mohammed Milhem
Clinical trials sponsored by Mohammed Milhem, explained in plain language.
-
Old drug, new hope: chlorpromazine joins fight against brain cancer
Disease control CompletedThis early-phase study tested whether adding the drug chlorpromazine (normally used for other conditions) to standard chemotherapy and radiation is safe for people newly diagnosed with glioblastoma, an aggressive brain cancer. Ten adults participated to find the best dose and che…
Phase: PHASE1 • Sponsor: Mohammed Milhem • Aim: Disease control
Last updated May 17, 2026 10:42 UTC
-
New combo therapy shows promise for tough kidney cancer
Disease control CompletedThis study tested a combination of two drugs, axitinib and seleniomethionine, in 45 adults with advanced kidney cancer that had spread. The goal was to find a safe dose and see if the combination could help control the cancer. The trial was completed and focused on side effects a…
Phase: PHASE1, PHASE2 • Sponsor: Mohammed Milhem • Aim: Disease control
Last updated May 17, 2026 10:42 UTC